Article
Seroma control in axillary lymphadenectomy with Glubran 2® without drain. Multicenter, prospective, randomized, clinical trial. GALA-ND Study (Glubran, Axillary Lymphadenectomy, Ambulatory, No Drain)
2023-02-08
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Seroma after breast cancer surgery is a frequent entity, therefore different products have been described in literature with the aim to reduce it. The most studied ones have been the sealants products, being tested with aspirative drains. Symptomatic seroma represents the 19% after axillary lymphadenectomy without drains. The aim of this study is to analyse the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ff5c0d77-0f08-5c63-b630-b18afe2b55c5
- DOI
- 10.21203/rs.3.rs-2467802/v1
